Combinatorial use of sodium laurate with taurine or L-glutamine enhances colonic absorption of rebamipide, poorly absorbable antiulcer drug, without any serious histopathological mucosal damages

Masateru Miyake, Yoshikazu Oka, Takanori Minami, Hajime Toguchi, Masaaki Odomi, Ken Ichi Ogawara, Kazutaka Higaki, Toshikiro Kimura

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

We previously reported that the combinatorial use of sodium laurate (C12) with several amino acids such as taurine (Tau) and L-glutamine (L-Gln) enhanced the colonic absorption of phenol red with attenuating the local toxicity caused by C12. However, even these amino acids could not protect epithelial cells from being damaged if the mucosal damage got worse to the coagulation necrosis by an excessive dose of C12. Comparing C12 with sodium caprate (C10), used in drug products marketed, 100 μmol C10 was needed to exert the similar absorption-enhancement of rebamipide, a poorly absorbable antiulcer drug, to that by 10 μmol C12, and 100 μmol C10 was obviously more toxic to the mucosa than 10 μmol C12. The combinatorial use of C12 with Tau or L-Gln enhanced the colonic absorption of rebamipide four to nine times larger in AUC than the control. Histopathologic studies clearly showed that Tau and L-Gln exerted the cytoprotective action on epithelial cells suffering from slight damages such as shrinkage and exfoliation, more articulately at 6 h than at 1.5 h after dosing. In conclusion, the combinatorial use of C12 with Tau or L-Gln could lead to a novel formulation improving the bioavailability of poorly absorbable drugs without any serious local damages.

Original languageEnglish
Pages (from-to)911-921
Number of pages11
JournalJournal of Pharmaceutical Sciences
Volume92
Issue number4
DOIs
Publication statusPublished - Apr 1 2003

Fingerprint

lauric acid
Taurine
Glutamine
Pharmaceutical Preparations
Epithelial Cells
Phenolsulfonphthalein
Amino Acids
Poisons
Coagulation
Drug products
Biological Availability
Area Under Curve
Toxicity
Mucous Membrane
Necrosis
rebamipide

Keywords

  • Absorption enhancer
  • Cytoprotection
  • Histopathology
  • L-glutamine
  • Local toxicity
  • Sodium laurate
  • Taurine

ASJC Scopus subject areas

  • Drug Discovery
  • Organic Chemistry
  • Chemistry(all)
  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science

Cite this

Combinatorial use of sodium laurate with taurine or L-glutamine enhances colonic absorption of rebamipide, poorly absorbable antiulcer drug, without any serious histopathological mucosal damages. / Miyake, Masateru; Oka, Yoshikazu; Minami, Takanori; Toguchi, Hajime; Odomi, Masaaki; Ogawara, Ken Ichi; Higaki, Kazutaka; Kimura, Toshikiro.

In: Journal of Pharmaceutical Sciences, Vol. 92, No. 4, 01.04.2003, p. 911-921.

Research output: Contribution to journalArticle

Miyake, Masateru ; Oka, Yoshikazu ; Minami, Takanori ; Toguchi, Hajime ; Odomi, Masaaki ; Ogawara, Ken Ichi ; Higaki, Kazutaka ; Kimura, Toshikiro. / Combinatorial use of sodium laurate with taurine or L-glutamine enhances colonic absorption of rebamipide, poorly absorbable antiulcer drug, without any serious histopathological mucosal damages. In: Journal of Pharmaceutical Sciences. 2003 ; Vol. 92, No. 4. pp. 911-921.
@article{97dfa8a2ae184556a1bcbfdf7987cdda,
title = "Combinatorial use of sodium laurate with taurine or L-glutamine enhances colonic absorption of rebamipide, poorly absorbable antiulcer drug, without any serious histopathological mucosal damages",
abstract = "We previously reported that the combinatorial use of sodium laurate (C12) with several amino acids such as taurine (Tau) and L-glutamine (L-Gln) enhanced the colonic absorption of phenol red with attenuating the local toxicity caused by C12. However, even these amino acids could not protect epithelial cells from being damaged if the mucosal damage got worse to the coagulation necrosis by an excessive dose of C12. Comparing C12 with sodium caprate (C10), used in drug products marketed, 100 μmol C10 was needed to exert the similar absorption-enhancement of rebamipide, a poorly absorbable antiulcer drug, to that by 10 μmol C12, and 100 μmol C10 was obviously more toxic to the mucosa than 10 μmol C12. The combinatorial use of C12 with Tau or L-Gln enhanced the colonic absorption of rebamipide four to nine times larger in AUC than the control. Histopathologic studies clearly showed that Tau and L-Gln exerted the cytoprotective action on epithelial cells suffering from slight damages such as shrinkage and exfoliation, more articulately at 6 h than at 1.5 h after dosing. In conclusion, the combinatorial use of C12 with Tau or L-Gln could lead to a novel formulation improving the bioavailability of poorly absorbable drugs without any serious local damages.",
keywords = "Absorption enhancer, Cytoprotection, Histopathology, L-glutamine, Local toxicity, Sodium laurate, Taurine",
author = "Masateru Miyake and Yoshikazu Oka and Takanori Minami and Hajime Toguchi and Masaaki Odomi and Ogawara, {Ken Ichi} and Kazutaka Higaki and Toshikiro Kimura",
year = "2003",
month = "4",
day = "1",
doi = "10.1002/jps.10362",
language = "English",
volume = "92",
pages = "911--921",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Combinatorial use of sodium laurate with taurine or L-glutamine enhances colonic absorption of rebamipide, poorly absorbable antiulcer drug, without any serious histopathological mucosal damages

AU - Miyake, Masateru

AU - Oka, Yoshikazu

AU - Minami, Takanori

AU - Toguchi, Hajime

AU - Odomi, Masaaki

AU - Ogawara, Ken Ichi

AU - Higaki, Kazutaka

AU - Kimura, Toshikiro

PY - 2003/4/1

Y1 - 2003/4/1

N2 - We previously reported that the combinatorial use of sodium laurate (C12) with several amino acids such as taurine (Tau) and L-glutamine (L-Gln) enhanced the colonic absorption of phenol red with attenuating the local toxicity caused by C12. However, even these amino acids could not protect epithelial cells from being damaged if the mucosal damage got worse to the coagulation necrosis by an excessive dose of C12. Comparing C12 with sodium caprate (C10), used in drug products marketed, 100 μmol C10 was needed to exert the similar absorption-enhancement of rebamipide, a poorly absorbable antiulcer drug, to that by 10 μmol C12, and 100 μmol C10 was obviously more toxic to the mucosa than 10 μmol C12. The combinatorial use of C12 with Tau or L-Gln enhanced the colonic absorption of rebamipide four to nine times larger in AUC than the control. Histopathologic studies clearly showed that Tau and L-Gln exerted the cytoprotective action on epithelial cells suffering from slight damages such as shrinkage and exfoliation, more articulately at 6 h than at 1.5 h after dosing. In conclusion, the combinatorial use of C12 with Tau or L-Gln could lead to a novel formulation improving the bioavailability of poorly absorbable drugs without any serious local damages.

AB - We previously reported that the combinatorial use of sodium laurate (C12) with several amino acids such as taurine (Tau) and L-glutamine (L-Gln) enhanced the colonic absorption of phenol red with attenuating the local toxicity caused by C12. However, even these amino acids could not protect epithelial cells from being damaged if the mucosal damage got worse to the coagulation necrosis by an excessive dose of C12. Comparing C12 with sodium caprate (C10), used in drug products marketed, 100 μmol C10 was needed to exert the similar absorption-enhancement of rebamipide, a poorly absorbable antiulcer drug, to that by 10 μmol C12, and 100 μmol C10 was obviously more toxic to the mucosa than 10 μmol C12. The combinatorial use of C12 with Tau or L-Gln enhanced the colonic absorption of rebamipide four to nine times larger in AUC than the control. Histopathologic studies clearly showed that Tau and L-Gln exerted the cytoprotective action on epithelial cells suffering from slight damages such as shrinkage and exfoliation, more articulately at 6 h than at 1.5 h after dosing. In conclusion, the combinatorial use of C12 with Tau or L-Gln could lead to a novel formulation improving the bioavailability of poorly absorbable drugs without any serious local damages.

KW - Absorption enhancer

KW - Cytoprotection

KW - Histopathology

KW - L-glutamine

KW - Local toxicity

KW - Sodium laurate

KW - Taurine

UR - http://www.scopus.com/inward/record.url?scp=0037381429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037381429&partnerID=8YFLogxK

U2 - 10.1002/jps.10362

DO - 10.1002/jps.10362

M3 - Article

C2 - 12661076

AN - SCOPUS:0037381429

VL - 92

SP - 911

EP - 921

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 4

ER -